Marijuana Stocks News Abattis Bioceuticals Corp. (ATTBF) Rebrands as a Downstream Solutions Provider for the Cannabis Market Abattis Rebrands as a Downstream Solutions Provider for the Cannabis Market Abattis… J. PhillipMar 6, 2018
Marijuana Stocks News Tetra Bio-Pharma Inc. (TBPMF) Takes First Steps into European Medical Cannabis Market Tetra Bio-Pharma Takes First Steps into European Medical Cannabis Market Tetra Bio-Pharma… J. PhillipMar 6, 2018
Marijuana Stocks News Organigram Holdings Inc. (OGRMF) reports Health Canada approval of new grow rooms Organigram reports Health Canada approval of new grow rooms, increased yields and… J. PhillipMar 6, 2018
Marijuana Stocks News Namaste Technologies Inc. (NXTTF) Submits Health Canada ACMPR Affirmation of Readiness Namaste Submits Health Canada ACMPR Affirmation of Readiness Namaste Technologies Inc. (“Namaste”… J. PhillipMar 5, 2018
Marijuana Stocks News Abattis Bioceuticals Corp. (ATTBF) Successful Completion of Acquisition of Gabriola Green Farms Abattis Announces Successful Completion of Acquisition of Gabriola Green Farms Abattis Bioceuticals… J. PhillipMar 2, 2018
Marijuana Stocks News INSYS Therapeutics, Inc. (INSY) Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution INSYS Therapeutics Initiates Phase 3 Clinical Trial of Cannabidiol (CBD) Oral Solution… J. PhillipMar 2, 2018
Marijuana Stocks News CannTrust Holdings Inc. (CNTTF) starts trading on the Toronto Stock Exchange CannTrust™ starts trading on the Toronto Stock Exchange CannTrust Holdings Inc. (“CannTrust”… J. PhillipMar 2, 2018
Marijuana Stocks News Hemp, Inc. (HEMP) Applauds Advancement of Hemp Bills in Indiana Hemp, Inc. Applauds Advancement of Hemp Bills in Indiana Hemp, Inc. (OTC PINK:… J. PhillipMar 2, 2018
Marijuana Stocks News Namaste Technologies Inc. (NXTTF) Announces 2018 Board of Director Nominees Namaste Announces 2018 Board of Director Nominees Namaste Technologies Inc. (“Namaste” or… J. PhillipMar 1, 2018 18 shares 18 0 0
Marijuana Stocks News Cara Therapeutics (CARA) & Enteris BioPharma, Inc. Doses First Patient in Phase 1 Trial of Oral KORSUVA™ Enteris BioPharma’s “Feasibility-to-Licensing” Partner, Cara Therapeutics, Doses First Patient in Phase 1… J. PhillipMar 1, 2018
